6550--Blood Bank Tube Reagents

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

256-NETWORK CONTRACT OFFICE 16 (36C256)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36C25626Q1277

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Classification Code

6550

Additional Details
Set Aside

None

Place of Performance

Jackson, Mississippi, UNITED STATES

SourceSAM
Documents2
The Department of Veterans Affairs, through its 256-Network Contract Office 16, has issued a Combined Synopsis/Solicitation (Procurement Identifier: 36C25626Q1277) for the procurement of Blood Bank Tube Reagents. This opportunity is classified under NAICS code 325413, which pertains to In-Vitro Diagnostic Substance Manufacturing, and is further identified by Product Service Code 6550. The place of performance for this contract is Jackson, Mississippi. The primary objective of this procurement is to secure a reliable supply of blood bank tube reagents, which are essential for in-vitro diagnostic testing within the VA healthcare system. These reagents play a critical role in blood banking operations, supporting the accurate identification and compatibility testing of blood samples to ensure safe transfusion practices for veterans under the care of the Department of Veterans Affairs. Contractors responding to this solicitation will be expected to provide reagents that meet stringent quality and regulatory standards suitable for clinical laboratory use. The scope of work likely includes the timely delivery of specified reagents to the designated VA facility in Jackson, MS, with adherence to all applicable federal and industry requirements for in-vitro diagnostic substances. While the specific technical and performance requirements are detailed in the attached solicitation documents, interested vendors should be prepared to demonstrate their capability to supply high-quality, consistent, and compliant products. The procurement is being managed by the 256-Network Contract Office 16, a federal office within the Department of Veterans Affairs. The primary point of contact for this opportunity is William Shaver, who can be reached via email at [email protected] for any questions or clarifications regarding the solicitation. This notice is currently active, with a response deadline set for August 31, 2026, at 12:08. Contractors are encouraged to review the full solicitation and its attachments, available through the provided SAM.gov link, to ensure a comprehensive understanding of the requirements and submission procedures. No information regarding set-aside status or special considerations is provided in the notice; interested parties should consult the solicitation documents for further details. This opportunity is well-suited for manufacturers and suppliers with experience in producing and distributing in-vitro diagnostic reagents, particularly those with a track record of serving federal healthcare institutions. Contractors should ensure their offerings align with the VA’s quality expectations and regulatory compliance needs throughout the contract lifecycle.